The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis

A Pozdnyakov, R Kulanthaivelu, G Bauman… - Prostate Cancer and …, 2023 - nature.com
Background Prostate-specific membrane antigen (PSMA) PET is highly sensitive in
identifying disease recurrence in men with biochemical recurrence of prostate cancer (BCR) …

[HTML][HTML] Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions

R Kucera, L Pecen, O Topolcan, AR Dahal… - EPMA Journal, 2020 - Springer
In the early twenty-first century, societies around the world are facing the paradoxal
epidemic development of PCa as a non-communicable disease. PCa is the most frequently …

A prospective study on 18F-DCFPyL PSMA PET/CT imaging in biochemical recurrence of prostate cancer

E Rousseau, D Wilson, F Lacroix-Poisson… - Journal of Nuclear …, 2019 - Soc Nuclear Med
18F-DCFPyL (2-(3-{1-carboxy-5-[(6-18F-fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-
pentanedioic acid), a prostate-specific membrane antigen–targeting radiotracer, has shown …

[HTML][HTML] Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]

J Calais, J Czernin, WP Fendler, D Elashoff… - BMC cancer, 2019 - Springer
Background Salvage radiotherapy (SRT) for prostate cancer (PCa) recurrence after
prostatectomy offers long-term biochemical control in about 50–60% of patients. SRT is …

[HTML][HTML] [68Ga] Ga-PSMA-11 in prostate cancer: a comprehensive review

F Bois, C Noirot, S Dietemann, IC Mainta… - American Journal of …, 2020 - ncbi.nlm.nih.gov
Imaging of the prostate-specific membrane antigen (PSMA) has become an important tool
for managing patients with recurrent prostate cancer, and one of the most frequently …

Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer

DA Ferraro, HI Garcia Schüler, UJ Muehlematter… - European journal of …, 2020 - Springer
Background Accurate staging is of major importance to determine the optimal treatment
modality for patients with prostate cancer. Positron emission tomography (PET) with prostate …

Expanding the role of small-molecule PSMA ligands beyond PET staging of prostate cancer

S Siva, C Udovicich, B Tran, H Zargar… - Nature Reviews …, 2020 - nature.com
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is rapidly
being established as arguably the leading contemporary imaging modality in the …

Impact of 68Ga-PSMA PET/CT on the radiotherapeutic approach to prostate cancer in comparison to CT: a retrospective analysis

NS Schmidt-Hegemann, C Eze, M Li… - Journal of Nuclear …, 2019 - Soc Nuclear Med
68Ga-prostate-specific membrane antigen PET/CT (68Ga-PSMA PET/CT) offers
unprecedented accuracy for staging of primary, persistent, or recurrent prostate cancer …

[HTML][HTML] High detection rate in [18F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients

T Watabe, M Uemura, F Soeda, S Naka, T Ujike… - Annals of Nuclear …, 2021 - Springer
Objective 18 F-labeled prostate-specific membrane antigen (PSMA) ligand,[18 F] PSMA-
1007, has the benefit of a higher synthetic yield and minimal excretion in the urine. High …

Detection rate and localization of prostate cancer recurrence using 68Ga-PSMA-11 PET/MRI in patients with low PSA values≤ 0.5 ng/mL

B Kranzbühler, J Müller, AS Becker… - Journal of Nuclear …, 2020 - Soc Nuclear Med
A first analysis of simultaneous 68Ga-prostate-specific membrane antigen (PSMA)-11
PET/MRI showed some improvement in the detection of recurrent disease at low serum …